日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma

皮下注射莫苏妥珠单抗联合来那度胺及单药治疗日本复发/难治性滤泡性淋巴瘤患者的疗效和安全性

Makita, Shinichi; Izutsu, Koji; Mishima, Yuko; Kumode, Takahiro; Kuroda, Junya; Kanemura, Nobuhiro; Fukuhara, Noriko; Shimada, Kazuyuki; Mori, Chiemi; Kawasaki, Atsuko; Miyake, Takeshi; Maruyama, Dai

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

PI3Kδ抑制剂帕沙克利布治疗日本复发或难治性滤泡性淋巴瘤患者

Fukuhara, Noriko; Yoshida, Isao; Ishiguro, Takuro; Fujimoto, Katsuya; Kuroda, Junya; Uchida, Toshiki; Yamamoto, Ryusuke; Ogawa, Yoshiaki; Hiramatsu, Yasushi; Ito, Toshiro; Katagiri, Seiichiro; Nakazato, Tomonori; Suzukawa, Kazumi; Kinami, Kenzo; Zhou, Mi; Negoro, Eiju

Case Report: Immunophenotypically diverse immature patterns, including variable TdT expression, in aggressive B-cell lymphomas and leukemia with MYC rearrangement

病例报告:MYC重排的侵袭性B细胞淋巴瘤和白血病中免疫表型多样化的未成熟模式,包括TdT表达的变异性

Kato, Daishi; Fujino, Takahiro; Isa, Reiko; Okamoto, Haruya; Tsukamoto, Taku; Mizutani, Shinsuke; Shimura, Yuji; Kobayashi, Tsutomu; Uchiyama, Hitoji; Taniwaki, Masafumi; Miyagawa-Hayashino, Aya; Kuroda, Junya

Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study

TET2 突变对急性髓系白血病患者预后的影响:HM-SCREEN-Japan 01 和 02 研究

Iyama, Satoshi; Chi, SungGi; Idogawa, Masashi; Ikezoe, Takayuki; Fukushima, Kentaro; Utsu, Yoshikazu; Kanda, Junya; Yoshimoto, Goichi; Kobayashi, Takahiro; Hosono, Naoko; Yamauchi, Takahiro; Kondo, Takeshi; Nakamura, Yukinori; Kojima, Kensuke; Yoshida, Chikashi; Gotoh, Akihiko; Yamamoto, Kazuhito; Kuroda, Junya; Ishitsuka, Kenji; Sakaida, Emiko; Horiguchi, Hiroto; Takada, Kohichi; Ohnishi, Hirofumi; Kobune, Masayoshi; Minami, Yosuke

Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351

基因突变与日本高危急性髓系白血病患者预后之间的关联:NS-87/CPX-351 的 1/2 期研究

Makishima, Hideki; Mikasa, Taisuke; Isogaya, Kento; Miyamoto, Toshihiro; Yamauchi, Takuji; Yokota, Akira; Onozawa, Masahiro; Ando, Kiyoshi; Ogawa, Yoshiaki; Usuki, Kensuke; Yamauchi, Takahiro; Ota, Shuichi; Takada, Satoru; Morita, Yasuyoshi; Ishikawa, Takayuki; Takenaka, Katsuto; Kuroda, Junya; Sekiguchi, Naohiro; Kawakita, Toshiro; Miyazaki, Yasushi

The Emergence of Subclones Following Initial Chemotherapy in Mixed Phenotype Acute Leukemia

混合表型急性白血病患者接受初始化疗后出现亚克隆

Murao, Taichi; Yamane, Yusuke; Kiyota, Miki; Shiozaki, Naoko; Wada, Katsuya; Kamitsuji, Yuri; Kuroda, Junya; Kawata, Eri

Late-Onset Angioimmunoblastic T-cell Lymphoma During Nivolumab Treatment for Melanoma

在接受纳武利尤单抗治疗黑色素瘤期间发生迟发性血管免疫母细胞性T细胞淋巴瘤

Miyashita, Akihiro; Murao, Taichi; Shimura, Yuji; Okamoto, Haruya; Nagata, Hiroaki; Onishi, Akio; Fujino, Takahiro; Mizutani, Shinsuke; Tsukamoto, Taku; Kuroda, Junya

Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic Encephalitis

原发性皮肤CD8阳性侵袭性表皮趋向性细胞毒性T细胞淋巴瘤并发副肿瘤性脑炎

Inoue, Yu; Tsukamoto, Taku; Mizuhara, Kentaro; Maekura, Chika; Nakamura, Takahisa; Okamoto, Haruya; Fujino, Takahiro; Mizutani, Shinsuke; Shimura, Yuji; Maruyama, Ayano; Nakanishi, Mari; Tanaka, Eijirou; Nishida, Yuki; Ishii, Kenta; Sonobe, Yuta; Miyagawa-Hayashino, Aya; Kuroda, Junya

Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results

妥昔诺司他治疗复发或难治性外周T细胞淋巴瘤患者的长期疗效和安全性:IIb期最终分析结果

Rai, Shinya; Kim, Won Seog; Ando, Kiyoshi; Choi, Ilseung; Izutsu, Koji; Tsukamoto, Norifumi; Maruyama, Dai; Tsukasaki, Kunihiro; Kuroda, Junya; Ando, Jun; Hidaka, Michihiro; Koh, Youngil; Kato, Hisashi; Uchida, Toshiki; Yang, Deok Hwan; Ishitsuka, Kenji; Ishizawa, Kenichi; Kim, Jin Seok; Lee, Hong Ghi; Minami, Hironobu; Eom, Hyeon Seok; Kurosawa, Mitsutoshi; Lee, Jae Hoon; Lee, Jong Seok; Lee, Won Sik; Nagai, Hirokazu; Shindo, Takero; Yoon, Dok Hyun; Yoshida, Shinichiro; Gillings, Mireille; Onogi, Hiroshi; Tobinai, Kensei

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

淋巴细胞/单核细胞比值可预测伊沙妥昔单抗联合泊马度胺治疗多发性骨髓瘤患者的疗效

Shimazu, Yutaka; Kanda, Junya; Onda, Yoshiyuki; Fuchida, Shin-Ichi; Ohta, Kensuke; Shimura, Yuji; Kosugi, Satoru; Yamamura, Ryosuke; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Adachi, Yoko; Anzai, Naoyuki; Hotta, Masaaki; Fukushima, Kentaro; Yagi, Hideo; Yoshihara, Satoshi; Tanaka, Yasuhiro; Takakuwa, Teruhito; Tanaka, Hirokazu; Shibayama, Hirohiko; Uoshima, Nobuhiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Matsumura, Itaru; Kuroda, Junya; Takaori-Kondo, Akifumi; Hino, Masayuki